RBQM Resources

  1. Site Tech, Integration, And Reducing Burden 6/12/2026

    Beth Harper, Rosie Filling, and Joe Dustin discuss site tech, integration, and how sponsors can reduce burden while improving flow.

  2. Why Standards Matter At Scale 6/12/2026

    Joe Dustin shows why custom integrations do not scale and why standards are essential for efficiently connecting many sites.

  3. RBQM For Decentralized Trials: Two Key Areas Of Focus To Reduce Your Risk 9/26/2022

    This article takes a more in-depth look at Sections 5.0.5: ‘Risk Communication’ and 5.0.6: ‘Risk Review.’ in ICH-GCP E6 R2 to show how the implementation of RBQM can reduce issues and achieve holistic trial oversight in today’s complex decentralized trials.

  4. Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call 3/21/2025

    Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.

  5. Ask Sites What Technology They Already Use 6/12/2026

    Rosie Filling says sponsors should stop guessing and ask sites what tech they use so teams can design with sites, not just for them.

  6. Why Site Burden Goes Beyond eSource 6/12/2026

    Beth Harper explains why the real problem is broader than eSource and why sponsors should integrate around the systems sites already use.

  7. How Risk-Aware Are You? Establishing A Foundation For A Holistic RBQM Strategy 10/3/2022

    This paper highlights why the industry is moving towards RBQM and how sponsors can build a scalable approach that protects trial participants, upholds study integrity, and increases operational efficiencies.

  8. Restoring The American Biotechnology Edge 10/13/2026

    Michelle Longmire explores why startup delays, enrollment friction, fragmented systems, and rising costs put trials at a competitive disadvantage.

  9. How Analytics Are Shaping The Future Of Clinical Trial Risk Management 5/26/2023

    Explore how analytics are revolutionizing clinical trial risk management and shaping the future of risk mitigation.

  10. Practical ICH E6(R3) Oversight For Your Centralized Monitoring Strategy 3/17/2026

    Bridge the gap between fragmented data and ICH E6(R3) compliance. Learn to use unified data signals to catch consent errors and enrollment delays before they trigger audit findings.